Glucose variability to predict new onset of diabetes
Diabetes of the exocrine pancreas constitutes around 1.6% of all new-onset diabetes in adults. Its most common subtype, post-pancreatitis diabetes mellitus, is associated with a 13% higher risk of all-cause mortality than type 2 diabetes. Acute pancreatitis (AP) is the largest contributor to diabetes of the exocrine pancreas.
In a recent study, published in the United European Gastroenterology Journal on February 20, 2022. researchers reported that glucose variability (GV) during hospitalisation for acute pancreatitis accurately predicts future risk of developing deranged glucose metabolism, including new-onset diabetes after acute pancreatitis.
For more information check out the full story on the link:
Glucose Variability During Early Course Of Acute Pancreatitis Can Predict New-Onset Of Diabetes
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.